Literature DB >> 9490326

Salivary concentrations of atrazine reflect free atrazine plasma levels in rats.

C Lu1, L C Anderson, M S Morgan, R A Fenske.   

Abstract

The protein binding of atrazine in plasma and its effect on salivary excretion of atrazine was determined in male Sprague-Dawley rats. The degree of protein binding of atrazine was determined at 3 steady-state plasma concentrations, 50, 150, and 250 microg/L, using an ultrafiltration technique. In total, 48 arterial blood samples were collected from 18 rats; 38 of 48 blood samples had their time-matched whole saliva samples. The average protein binding of atrazine ranged from 18% to 37%; however, it was not significantly different across the 3 steady-state plasma concentrations nor among the individual rats. Overall, 26% of atrazine was bound to plasma proteins and not available for transport from blood into saliva. Protein binding of atrazine in plasma was not correlated with total atrazine plasma concentration nor with free atrazine plasma concentration, which indicates that the protein-bound fraction of atrazine is independent of plasma concentration within the range measured in this study (30-400 microg/L). The average saliva/plasma (S/P) concentration ratio of atrazine increased from 0.7 using total atrazine plasma concentration to 0.94 (S/fP) when free atrazine plasma concentrations calculated as 26% of protein binding was used. Salivary concentration was highly correlated with free atrazine plasma concentration. The results suggest that salivary concentration of atrazine not only reflects its total plasma level but accurately measures the portion of atrazine (free atrazine) in plasma, which may be of toxicological significance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490326     DOI: 10.1080/009841098159286

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  7 in total

Review 1.  Saliva as a matrix for human biomonitoring in occupational and environmental medicine.

Authors:  Bernhard Michalke; Bernd Rossbach; Thomas Göen; Anja Schäferhenrich; Gerhard Scherer
Journal:  Int Arch Occup Environ Health       Date:  2014-03-12       Impact factor: 3.015

2.  The need for non- or minimally-invasive biomonitoring strategies and the development of pharmacokinetic/pharmacodynamic models for quantification.

Authors:  Charles Timchalk; Thomas J Weber; Jordan N Smith
Journal:  Curr Opin Toxicol       Date:  2017-06

Review 3.  Biomonitoring of exposure in farmworker studies.

Authors:  Dana B Barr; Kent Thomas; Brian Curwin; Doug Landsittel; James Raymer; Chensheng Lu; K C Donnelly; John Acquavella
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

Review 4.  Computational strategy for quantifying human pesticide exposure based upon a saliva measurement.

Authors:  Charles Timchalk; Thomas J Weber; Jordan N Smith
Journal:  Front Pharmacol       Date:  2015-05-27       Impact factor: 5.810

5.  Characterizing exposures to nonpersistent pesticides during pregnancy and early childhood in the National Children's Study: a review of monitoring and measurement methodologies.

Authors:  Asa Bradman; Robin M Whyatt
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

6.  Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children's Study.

Authors:  Dana B Barr; Richard Y Wang; Larry L Needham
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

7.  Biomonitoring in the Era of the Exposome.

Authors:  Kristine K Dennis; Elizabeth Marder; David M Balshaw; Yuxia Cui; Michael A Lynes; Gary J Patti; Stephen M Rappaport; Daniel T Shaughnessy; Martine Vrijheid; Dana Boyd Barr
Journal:  Environ Health Perspect       Date:  2016-07-06       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.